Stool Reducing Substance Testing in Newborns
In a breast-fed newborn, a positive stool reducing substance test (>0.5%) without clinical symptoms is NOT diagnostic of lactose intolerance and should not prompt dietary changes. 1
Clinical Interpretation
What the Test Actually Indicates
- The presence of low pH (<6.0) or reducing substances (>0.5%) in stool WITHOUT clinical symptoms does NOT diagnose lactose intolerance 1
- True lactose intolerance is a clinical diagnosis requiring more severe diarrhea upon introduction of lactose-containing foods, not just abnormal stool chemistry 1
- Lactase deficiency must be distinguished from lactose malabsorption—many infants with lactase deficiency will not have clinical malabsorption 1
Common Pitfall to Avoid
Do not change feeding based solely on stool test results. The CDC guidelines explicitly state that stool reducing substances >0.5% in the absence of clinical symptoms are not diagnostic 1. This is a critical distinction that prevents unnecessary dietary restrictions.
Management Algorithm for Breast-Fed Infants
If Stool Test is Positive BUT Infant is Asymptomatic:
- Continue breast-feeding on demand without interruption 1
- No dietary changes are warranted 1
- Monitor for development of actual clinical symptoms (see below)
If Stool Test is Positive AND Clinical Symptoms Present:
Look for these specific clinical indicators of true carbohydrate malabsorption:
- Exacerbation of diarrhea (increased frequency, volume, or watery consistency) 1
- Poor weight gain 1
- Feeding refusal or irritability during/after feeds 1
If symptomatic:
- For breast-fed infants: Consider a 2-4 week trial of maternal exclusion diet restricting at least milk and egg 2
- Breast-feeding should still continue during this trial when possible 1
- If lactose intolerance is confirmed clinically, temporary reduction or removal of lactose from the diet is appropriate 1
Evidence Quality Considerations
Why This Test Performs Poorly
Recent research demonstrates that stool reducing sugars have only 9-28% sensitivity and 74-81% specificity for disaccharidase deficiencies 3. Even in infants (who have the highest rate of abnormal results), the positive predictive value is only 50-54% 3.
The test should not be used as a screening tool for carbohydrate malabsorption 3. A 1972 study confirmed that while >0.5% reducing substances can be a screening test, it must be correlated with clinical findings 4.
Supporting Evidence for Continued Breast-Feeding
- Despite concerns about lactose malabsorption, continued breast-feeding during diarrheal illness is clinically well-tolerated and advantageous 1
- Breast-fed children who continued nursing during acute diarrhea had reduced stool output compared to those who did not 1
- 88% of patients hospitalized with rotavirus diarrhea had evidence of lactose malabsorption, yet most tolerated continued feeding 1
Key Takeaway
The stool reducing substance test generates significant false-positive results in asymptomatic newborns and should never be the sole basis for dietary intervention. 3 Clinical symptoms—specifically worsening diarrhea with lactose introduction—are required to diagnose true lactose intolerance 1. In breast-fed infants, continue nursing regardless of test results unless clear clinical deterioration occurs 1.